Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Chin Med J (Engl). 2013 Jan;126(2):335-9.
For muscle invasive bladder cancer, radical cystectomy is the most effective treatment now and urinary diversion is often necessary. The use of intestinal tissue for urinary diversion is frequently associated with complications. In this study, we aimed to make a tissue-engineered conduit (TEC) using bladder epithelial cells and bladder acellular matrix (BAM) for urinary diversion in rabbits.
Bladder epithelial cells of rabbit were cultivated and expanded in vitro, then seeded on BAM, and cultured for 7 days. Then cell-seeded graft was used to make TEC. In the experimental group, most of bladder of the rabbit was removed while bladder trigone was retained. The proximal end of TEC was anastomosed with bladder trigone and the distal end was anastomosed with the abdominal stoma. In the control group, TEC was made using unseeded BAM. Haematoxylin and eosin staining was conducted, respectively, at 1, 2, 4, and 8 weeks postoperatively. Immunohistochemistry was performed 8 weeks postoperatively. Intravenous urography, retrograde pyelography, and cystoscopy of TEC were made at 12 weeks postoperatively.
All animals were alive in the experimental group. Haematoxylin and eosin staining showed epithelial coverage in TEC. Immunohistochemistry showed anti-cytokeratin AE(1)/AE(3) antibody and anti-ZO1 antibody positive, confirming there were mature and functional epithelial cells on the lumen of TEC. Retrograde pyelography and intravenous urography showed that TEC developed well and that there was no obstruction. In the control group, four rabbits were dead within 2 weeks and scar formation, atresia, and severe hydronephrosis were found.
We successfully made TEC using BAM and bladder epithelial cells for urinary diversion in rabbits. The lumen of this new TEC covered mature epithelial cells and could prevent urinary extravasation.
对于肌层浸润性膀胱癌,根治性膀胱切除术是目前最有效的治疗方法,通常需要进行尿流改道。使用肠组织进行尿流改道常伴有并发症。在这项研究中,我们旨在使用兔膀胱上皮细胞和膀胱去细胞基质(BAM)制造组织工程导管(TEC)用于兔的尿流改道。
体外培养和扩增兔膀胱上皮细胞,然后接种到 BAM 上,培养 7 天。然后将细胞接种移植物用于制造 TEC。在实验组中,大部分兔膀胱被切除,而保留膀胱三角区。TEC 的近端与膀胱三角区吻合,远端与腹部造口吻合。在对照组中,使用未接种的 BAM 制造 TEC。分别在术后 1、2、4 和 8 周进行苏木精和伊红染色。术后 8 周行免疫组织化学检查。术后 12 周行静脉尿路造影、逆行肾盂造影和 TEC 膀胱镜检查。
实验组所有动物均存活。苏木精和伊红染色显示 TEC 有上皮覆盖。免疫组织化学显示抗细胞角蛋白 AE(1)/AE(3)抗体和抗 ZO1 抗体阳性,证实 TEC 管腔中有成熟和功能的上皮细胞。逆行肾盂造影和静脉尿路造影显示 TEC 发育良好,无梗阻。对照组中,有 4 只兔子在 2 周内死亡,且发现有瘢痕形成、闭锁和严重的肾盂积水。
我们成功地使用 BAM 和兔膀胱上皮细胞制造了用于尿流改道的 TEC。这种新 TEC 的管腔覆盖有成熟的上皮细胞,可以防止尿液外渗。